Possibilities for the co-use of high-frequency skin ultrasound and contrast-enhanced renal ultrasound in the diagnosis of chronic kidney disease

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

In Russia, decreased kidney function was diagnosed in 16% of able-bodied people and in 36% of people over 60 years of age. It is necessary to develop additional algorithms for diagnosing this disease for its early detection at the stage of screening, monitoring the development of pathology, and preventing complications. Objective. To evaluate the effectiveness of co-use of high-frequency skin ultrasound and contrast-enhanced renal ultrasound in the diagnosis of chronic kidney disease (CKD). Subjects and methods. The investigation enrolled 34 patients with a documented CKD diagnosis. The patients were divided into groups according to the glomerular filtration rate (GFR): Group 1 consisted of 17 patients with normal or slightly reduced GFR (>60 ml/min/1.73m2); Group 2 included 17 patients with significantly reduced GFR (30-44 ml/min/1.73 m2). The patients were examined according to the unified diagnostic algorithm: B-mode multiparametric renal ultrasound, contrast-enhanced renal ultrasound with the co-application of high-frequency skin ultrasound. Results. The proposed method for determining the severity of CKD, by assessing peripheral microcirculatory abnormalities using contrast-enhanced renal ultrasound and high-frequency skin ultrasound before and during intravenous contrast enhancement, by determining the difference between the values of ratio of acoustic scan lines, showed a high sensitivity (89.5%) and specificity (90.6%). Conclusion. The co-use of high-frequency skin ultrasound and contrast-enhanced renal ultrasound is effective in detecting and monitoring CKD.

Full Text

Restricted Access

About the authors

A. V. Borsukov

Smolensk State Medical University Ministry of Health of Russia

Author for correspondence.
Email: 92darv@gmail.com

Professor, MD

O. A. Gorbatenko

Smolensk State Medical University Ministry of Health of Russia

Email: 92darv@gmail.com

D. Yu. Venidiktova

Smolensk State Medical University Ministry of Health of Russia

Email: 92darv@gmail.com

0000-0001-5497-1476

A. O. Tagil

Smolensk State Medical University Ministry of Health of Russia

Email: 92darv@gmail.com

S. A. Borsukov

Smolensk State Medical University Ministry of Health of Russia

Email: 92darv@gmail.com

V. S. Kurchenkova

Clinical Hospital One

Email: 92darv@gmail.com
Smolensk

References

  1. International Diabetes Federation, 2019. URL: https://www.idf.org/
  2. Клинические рекомендации Хроническая болезнь почек. Ассоциация нефрологов, 2021; с. 233.
  3. Sheiman J.A. Патофизиология почки. Пер. с англ. М.: «Издательство БИНОМ», 2019; 192 с.
  4. Claudon M., Dietrich C.F., Choi B.I., et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver - update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med. 2013; 34 (1): 11-29. doi: 10.1055/S-0032-1325499
  5. Барилко М., Селиверстов П., Радченко В. Дисбиоз толстой кишки и хроническая болезнь почек. Врач. 2019; 30 (2): 14-9. doi: 10.29296/25877305-2019-02-02
  6. Ультразвуковое исследование с применением контрастных препаратов. От простого к сложному. Под общ. ред. А.Н. Сенча. М.: МЕДпресс-информ, 2021; 296 с.
  7. Molvneux A.S. Neural control of arteriovenous anastomoses. Microvasc Res. 1980; 19 (2): 256-9.
  8. Родионов А.Н., Заславский Д.В., Сыдиков А.А. Клиническая дерматология. М.: ГЭОТАР-Медиа, 2019.
  9. Sidhu P.S., Cantisani V., Dietrich C.F. et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (long version). Ultraschall Med. 2018; 39 (2): e2-e44. DOI: 10.1055 /a-0586-1107
  10. Westwood M., Joore M., Grutters J. et al. Contrast-enhanced ultrasound using SonoVue® (sulfur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterization of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2013; 17 (16): 1-243. doi: 10.3310/hta17160
  11. Weskott H.-P. Контрастная сонография. 1-е изд. Бремен: UNI-MED, 2014; 284 с.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Qualitative assessment of contrast-enhanced renal ultrasound in a Group 1 patient without CKD (а – arterial phase; б – venous phase) and a Group 2 patient with Stage 4 CKD (в – arterial phase; г – venous phase)

Download (375KB)
3. Fig. 2. Scheme for evaluating clinical CKD: 1 – a transducer; 2 – the palmar surface of the distal phalanx of the left middle finger; 3 – dermis; 4 – subcutaneous fat; 5 – skin area

Download (97KB)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies